Evidence map›Paper›PMID 39061777›Full record

ReviewBioengineering (Basel, Switzerland)2024

Emerging Medical Technologies and Their Use in Bionic Repair and Human Augmentation.

Albert Manero, Viviana Rivera, Qiushi Fu, Jonathan D Schwartzman, Hannah Prock-Gibbs, Neel Shah, Deep Gandhi, Evan White, Kaitlyn E Crawford, Melanie J Coathup

Abstract readReview
In one paragraph

Review in Bioengineering (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. My I Could Never Die.Maedica · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Albert ManeroLimbitless Solutions, University of Central Florida, 12703 Research Parkway, Suite 100, Orlando, FL 32826, USA.ORCID 0000-0003-0145-7582
Viviana RiveraLimbitless Solutions, University of Central Florida, 12703 Research Parkway, Suite 100, Orlando, FL 32826, USA.ORCID 0000-0001-5619-6135
Qiushi FuBiionix Cluster, University of Central Florida, Orlando, FL 32827, USA.
Jonathan D SchwartzmanCollege of Medicine, University of Central Florida, Orlando, FL 32827, USA.ORCID 0000-0002-1379-0529
Hannah Prock-GibbsCollege of Medicine, University of Central Florida, Orlando, FL 32827, USA.
Neel ShahCollege of Medicine, University of Central Florida, Orlando, FL 32827, USA.
Deep GandhiCollege of Medicine, University of Central Florida, Orlando, FL 32827, USA.
Evan WhiteCollege of Medicine, University of Central Florida, Orlando, FL 32827, USA.
Kaitlyn E CrawfordBiionix Cluster, University of Central Florida, Orlando, FL 32827, USA.
Melanie J CoathupBiionix Cluster, University of Central Florida, Orlando, FL 32827, USA.ORCID 0000-0002-4543-4756

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As both the proportion of older people and the length of life increases globally, a rise in age-related degenerative diseases, disability, and prolonged dependency is projected. However, more sophisticated biomedical materials, as well as an improved understanding of human disease, is forecast to revolutionize the diagnosis and treatment of conditions ranging from osteoarthritis to Alzheimer's disease as well as impact disease prevention. Another, albeit quieter, revolution is also taking place within society: human augmentation. In this context, humans seek to improve themselves, metamorphosing through self-discipline or more recently, through use of emerging medical technologies, with the goal of transcending aging and mortality. In this review, and in the pursuit of improved medical care following aging, disease, disability, or injury, we first highlight cutting-edge and emerging materials-based neuroprosthetic technologies designed to restore limb or organ function. We highlight the potential for these technologies to be utilized to augment human performance beyond the range of natural performance. We discuss and explore the growing social movement of human augmentation and the idea that it is possible and desirable to use emerging technologies to push the boundaries of what it means to be a healthy human into the realm of superhuman performance and intelligence. This potential future capability is contrasted with limitations in the right-to-repair legislation, which may create challenges for patients. Now is the time for continued discussion of the ethical strategies for research, implementation, and long-term device sustainability or repair.

Indexed as

biohackingbrain–machine interfaceethicsexoskeletonshuman augmentationneuroprosthetics

Identifiers

PMID39061777
PMCPMC11274085

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.